
Avinger AVGR
Quarterly report 2024-Q3
added 11-07-2024
Avinger Interest Expense 2011-2026 | AVGR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.72 M | 1.66 M | 1.65 M | 1.69 M | 1.48 M | 5.69 M | 6.3 M | 5.52 M | 5.17 M | 6.02 M | 2.93 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.3 M | 1.48 M | 3.62 M |
Quarterly Interest Expense Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48 K | 234 K | 416 K | - | 455 K | 445 K | 392 K | - | 407 K | 440 K | 439 K | - | 419 K | 399 K | 396 K | - | 433 K | 414 K | 398 K | - | 377 K | 364 K | 350 K | - | 324 K | 362 K | 4.67 M | - | 1.6 M | 1.57 M | 1.55 M | - | 1.55 M | 1.24 M | 1.17 M | - | 1.33 M | 1.34 M | 1.32 M | - | 1.71 M | 1.62 M | 1.57 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.67 M | 48 K | 902 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 20.62 | -2.02 % | $ 2.95 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.94 | -4.88 % | $ 642 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.51 | 0.29 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 94.69 | -0.69 % | $ 139 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 302.54 | -0.15 % | $ 8.54 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 47.03 | -0.17 % | $ 7.01 K | ||
|
Electromed
ELMD
|
78 K | $ 28.76 | -1.25 % | $ 243 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.33 | -0.77 % | $ 216 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.29 | - | $ 123 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.43 | 0.15 % | $ 1.23 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 61.5 | -0.06 % | $ 3.34 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.7 | 0.6 % | $ 135 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
7.68 M | $ 155.44 | -0.45 % | $ 11.6 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.84 | 1.76 % | $ 86.3 M | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.64 | -0.41 % | $ 369 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.55 | -0.05 % | $ 122 M | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 14.94 | -1.45 % | $ 570 M | ||
|
AxoGen
AXGN
|
-199 K | $ 31.45 | -3.91 % | $ 1.39 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.79 | 0.47 % | $ 1.26 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 7.57 | -3.88 % | $ 180 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.51 | -1.44 % | $ 404 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 86.48 | -0.95 % | $ 11.7 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.35 | -0.56 % | $ 951 M |